Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Thursday, April 18, 2024 · 704,601,562 Articles · 3+ Million Readers

CLASS ACTION UPDATE for MFGP REPH and HAIR: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court; further details about the cases can be found at the links provided.

Micro Focus International plc (NYSE:MFGP)
Class Period: September 1, 2017 - March 19, 2018, and/or pursuant to the August 4, 2017 Registration Statement or August 22, 2017 Prospectus
Lead Plaintiff Deadline: July 23, 2018

According to the complaint, the Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading information and/or failed to disclose material information, and Micro Focus made materially false and misleading statements and/or failed to disclose material information throughout the class period.

To learn more about the Micro Focus class action go to:  http://www.zlk.com/pslra-d/micro-focus-international-plc?wire=3.

Recro Pharma, Inc. (NASDAQ:REPH)
Class Period: July 31, 2017 and May 23, 2018
Lead Plaintiff Deadline: July 30, 2018

According to the complaint, the Company's lead product, IV meloxicam, lacked supporting clinical data to show sufficient clinical benefits to receive U.S. Food and Drug Administration ("FDA") approval; and as a result, Recro Pharma's public statements were materially false and misleading at all relevant times. On May 24, 2018, Recro Pharma announced that the FDA had declined to approve its New Drug Application ("NDA") for IV meloxicam. In its Complete Response Letter, the FDA stated that the drug's analgesic effects did not meet FDA expectations and raised questions related to chemistry, manufacturing and controls data.

To learn more about the Recro Pharma class action go to:  http://www.zlk.com/pslra-d/recro-pharma-inc?wire=3.

Restoration Robotics, Inc. (NASDAQ:HAIR)
Class Period: purchases during the Initial public offering commenced on October 12, 2017 and closed on October 16, 2017
Lead Plaintiff Deadline: August 21, 2018

The complaint alleges that Restoration Robotics negligently issued untrue statements of material facts in, and omitted to state material facts required to be stated from, the Offering Materials issued in connection with the Initial Public Offering. The complaint further alleges that as a result of the materially misleading Offering Materials, the Company’s stock price was artificially inflated at the time of the IPO.

To learn more about the Restoration Robotics class action go to: http://www.zlk.com/pslra-d/restoration-robotics-inc?wire=3.

You have until the lead plaintiff deadlines to request the court appoint as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Primary Logo

Powered by EIN News
Distribution channels: Consumer Goods, Law


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release